Finerenone for diabetic kidney disease in African American veterans
Treatments studied
Part of Hormones & metabolism, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study tests whether finerenone, a medication that protects the kidneys and heart, can help African American veterans with type 2 diabetes and early kidney damage. If you qualify, you may receive the study drug and close monitoring of your kidney function and blood sugar.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an African American veteran age 20 to 90.
- You have type 2 diabetes (confirmed by blood tests like HbA1C or fasting glucose).
- Your kidney function test (eGFR) is between 25 and 89, with some protein in your urine (albuminuria 30 mg/g or higher).
- Your blood pressure is well-controlled (140/90 or lower), and your body mass index (BMI) is between 18 and 39.9.
- You are not currently smoking, do not have active skin wounds or recent surgery, and are not on dialysis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing a medication called finerenone to see how well it helps people with type 2 diabetes who also have chronic kidney disease. Researchers are looking at how the drug affects kidney function and related health factors.
This study is testing whether the drug empagliflozin (Jardiance) can help protect the kidneys of African American veterans who already have some kidney damage but do not have diabetes. The goal is to see if the drug can reduce damage at the cellular level.
This trial tests if a medicine called finerenone can protect kidney function in people with type 2 diabetes and early-to-moderate chronic kidney disease. It may be an option if you are already on blood pressure medication and have some protein in your urine.
This trial tests a medication called Finerenone to see if it can improve heart structure and function in people with both diabetic kidney disease and heart failure. If you have type 2 diabetes, kidney problems, and heart failure with preserved pumping function, this study may explore a new treatment option for you.
This trial tests whether adding finerenone to your current diabetes medications can better protect your heart and kidneys. It is for people with type 2 diabetes who already take an SGLT2 inhibitor and an ACE inhibitor or ARB.
This study tests whether finerenone, a pill that helps protect the kidneys and heart, can slow down kidney decline and reduce heart failure risk in people with type 2 diabetes and chronic kidney disease.
Hear when a new Diabetic Kidney Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.